Here are eight recent news updates on key gastroenterology and endoscopy companies.
Olympus is once again embroiled in controversy following the discovery of emails that show the company pushed up the price of duodenoscopes after the deadly Carbapenem-resistant Enterobacteria outbreak at UCLA's Ronald Reagan Medical Center, which left three dead.
Olympus unveiled the VISERA 4K UHD System.
Cairn Diagnostics launched the 13C-Spirulina Gastric Emptying Breath Test.
Zacks Investment Research upgraded EndoChoice Holdings from a "hold" rating to a "buy" rating.
Zydus Healthcare, a subsidiary of Cadila Healthcare, acquired gastrointestinal brand 'Actibile' from drug firm Albert David.
R. Gregory Scheible, MD, is the first physician Indiana to implant Apollo Endosurgery's Orbera intragastric balloon in a patient using a non-surgical procedure.
Clinical Genomics recently closed a $15 million series A financing round.
GI Dynamics appointed Scott Schorer as president and CEO, effective immediately.